Obviously, Chen et al. ascertained that the carriers of the TYMP rs11479-T allele partially triggered the high risk of HFS and grade 2 anemia [31], indicative of the stronger sensitivity of the T allele carriers to capecitabine versus C allele carriers. This evidence concerns the gene TYMP and anemia.